COLORECTAL ADENOCARCINOMA
Clinical trials for COLORECTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new COLORECTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for COLORECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to stop lung metastases in colorectal cancer
Disease control OngoingThis study tests whether combining chemotherapy with surgery to remove lung tumors works better than either treatment alone for people with colorectal cancer that has spread to the lungs. About 40 participants will be grouped by risk level and followed to see how long they live w…
Matched conditions: COLORECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:08 UTC
-
New drug cocktail shows promise for Tough-to-Treat colorectal cancer
Disease control OngoingThis study tests whether a combination of three drugs—temozolomide, cisplatin, and nivolumab—can shrink tumors in people with advanced colorectal cancer that has not responded to at least two prior treatments. The trial includes 18 adults whose cancer is mismatch repair-proficien…
Matched conditions: COLORECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:08 UTC
-
New drug TST003 tested in patients with advanced cancers
Disease control OngoingThis early-stage study tests a new drug called TST003 in about 111 adults with advanced solid tumors (cancers that have spread or cannot be removed by surgery). The main goals are to find a safe dose, check side effects, and see if the drug can shrink tumors. Participants receive…
Matched conditions: COLORECTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Transcenta Therapeutics Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 02:08 UTC
-
New study tests best timing for chemo and surgery in advanced colorectal cancer
Disease control OngoingThis study looks at whether giving chemotherapy before and after surgery (plus heated chemotherapy inside the abdomen) helps people with colorectal cancer that has spread to the lining of the belly live longer compared to having surgery alone. About 358 adults with resectable tum…
Matched conditions: COLORECTAL ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Koen Rovers • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
Could a chemo-immunotherapy combo tame hard-to-treat colorectal cancer?
Disease control OngoingThis study tests whether a short course of chemotherapy can make a type of advanced colorectal cancer (pMMR/MSS) more responsive to immunotherapy. The goal is to achieve long-term disease control or even eliminate tumors. About 80 adults with untreated, spread colorectal cancer w…
Matched conditions: COLORECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: University Hospital, Akershus • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
New combo shows promise for Hard-to-Treat colorectal cancer
Disease control OngoingThis study tests a combination of two drugs, cabozantinib and nivolumab, in people with advanced colorectal cancer that has not responded to standard treatments. The goal is to see if the combination can stop or shrink the cancer for at least 16 weeks. About 48 adults with a spec…
Matched conditions: COLORECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New hope for Tough-to-Treat colorectal cancer? drug combo trial underway
Disease control TerminatedThis study is for people with advanced colorectal cancer that has a specific genetic change called a KRAS mutation, and whose cancer has worsened after standard treatments. The goal is to test the safety of combining two drugs, AVUTOMETINIB and cetuximab, and find the best dose. …
Matched conditions: COLORECTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Vitamin D3 boost may slow advanced colon cancer, major trial underway
Disease control OngoingThis study tests whether adding high-dose vitamin D3 to standard chemotherapy and a targeted drug (bevacizumab) can help people with metastatic colorectal cancer live longer without their disease getting worse. About 455 patients who have not had prior treatment for advanced dise…
Matched conditions: COLORECTAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 14, 2026 12:07 UTC